Patents Assigned to Levolta Pharmaceuticals, Inc.
  • Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis
    Patent number: 9737553
    Abstract: A combination therapy for treating osteoarthritis is disclosed. The combination therapy includes the co-administration of a steroid and Zoledronic Acid. The coadministration of a steroid decreases the production of cytokines, and, therefore, decreases the pro-inflammatory effects of Zoledronic Acid. The co-administration of Zoledronic Acid with steroids treats osteoarthritis, and helps to prevent the onset of osteoarthritis in patients at risk for osteoarthritis.
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: August 22, 2017
    Assignee: Levolta Pharmaceuticals, Inc.
    Inventor: Ketan Desai
  • Small molecule inhibitors of protein kinases
    Patent number: 9212143
    Abstract: Compounds that modulate, for example, that inhibit, syk kinase, and, optionally other kinases. The compounds can be used to treat a variety of disorders, including inflammatory disorders and autoimmune disorders.
    Type: Grant
    Filed: November 2, 2010
    Date of Patent: December 15, 2015
    Assignee: LEVOLTA PHARMACEUTICALS, INC.
    Inventors: Ketan Desai, Renee Desai
  • Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis
    Patent number: 9012432
    Abstract: A combination therapy for treating osteoarthritis is disclosed. The combination therapy includes the co-administration of a steroid and Zoledronic Acid. The coadministration of a steroid decreases the production of cytokines, and, therefore, decreases the pro-inflammatory effects of Zoledronic Acid. The co-administration of Zoledronic Acid with steroids treats osteoarthritis, and helps to prevent the onset of osteoarthritis in patients at risk for osteoarthritis.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: April 21, 2015
    Assignee: Levolta Pharmaceuticals, Inc.
    Inventor: Ketan Desai